Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-02-03

Clinical Trial Update: Trial to Evaluate Tibolone in the Treatment of Osteoporosis (P06468) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating tibolone for osteoporosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tibolone (tibolone)

Snippet

Sponsor: Organon and Co | Conditions: Osteoporosis | Phase 3 | Status: COMPLETED